You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
McKesson
Boehringer Ingelheim
Express Scripts
Colorcon

Last Updated: July 16, 2020

DrugPatentWatch Database Preview

Meperidine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for meperidine hydrochloride and what is the scope of freedom to operate?

Meperidine hydrochloride is the generic ingredient in four branded drugs marketed by Hospira, Us Pharm Holdings, Abbott, Baxter Hlthcare, Igi Labs Inc, Intl Medication, Parke Davis, Watson Labs, West-ward Pharms Int, Icu Medical Inc, Specgx Llc, Hikma, Anda Repository, Barr, Duramed Pharms Barr, Epic Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Vintage Pharms, and Wyeth Ayerst, and is included in forty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for meperidine hydrochloride. Six suppliers are listed for this compound.

Recent Clinical Trials for meperidine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rajesh DesharN/A
Makassed General HospitalN/A
University of WashingtonPhase 4

See all meperidine hydrochloride clinical trials

Pharmacology for meperidine hydrochloride
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for meperidine hydrochloride

US Patents and Regulatory Information for meperidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anda Repository MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040893-003 Jun 24, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 021171-002 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
West-ward Pharms Int MEPERIDINE HYDROCHLORIDE meperidine hydrochloride INJECTABLE;INJECTION 080455-007 Approved Prior to Jan 1, 1982 AP RX No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int MEPERIDINE HYDROCHLORIDE meperidine hydrochloride INJECTABLE;INJECTION 080445-001 Approved Prior to Jan 1, 1982 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
McKesson
Boehringer Ingelheim
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.